Related Experiment Video
Updated: Apr 30, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report
Masayuki Nogi1, David Fergusson1, John Michael Chua Chiaco1
1Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI (MN).
Insights
This case report details a rare instance of mid-ventricular takotsubo cardiomyopathy in a patient with Cannabinoid Hyperemesis Syndrome (CHS). The findings suggest a potential link between cannabinoid use and cardiac dysfunction.
Area of Science:
- Cardiology
- Toxicology
- Gastroenterology
Background:
- Takotsubo cardiomyopathy (TCM) is a stress-induced cardiac dysfunction.
- Cannabinoid Hyperemesis Syndrome (CHS) is characterized by cyclic nausea, vomiting, and compulsive bathing in chronic cannabis users.
Observation:
- A 32-year-old woman with CHS presented with epigastric pain, nausea, and vomiting.
- EKG revealed dynamic T-wave changes and elevated cardiac biomarkers.
- Echocardiography and angiography confirmed the mid-ventricular variant of TCM with normal coronary arteries.
Findings:
- The patient's symptoms recurred with marijuana resumption, consistent with CHS.
- This case represents a rare association between CHS and TCM.
- Endocannabinoid receptors in the myocardium may mediate cannabinoid-induced cardiac effects.
Implications:
- This case highlights a potential, though mechanistically undefined, relationship between CHS and TCM.
- Further research is warranted to explore the cardiac manifestations of cannabinoid use.
- Clinicians should consider cardiac evaluation in patients with CHS presenting with relevant symptoms.
Abstract:
A case of the mid-ventricular variant of takotsubo cardiomyopathy is reported, occurring in a patient with Cannabinoid Hyperemesis Syndrome (CHS), and presented with a review of the relevant literature. The patient is a 32-year-old woman who presented with epigastric pain, nausea and vomiting. Her EKG showed dynamic T-wave changes associated with a modest cardiac biomarker elevation. Ventricular wall motion abnormalities suggestive of the mid-ventricular variant of takotsubo cardiomyopathy were demonstrated by echocardiography, ventriculography and cardiac angiography, the latter showing normal coronary arteries. The patient was a previous marijuana user who had recently ingested marijuana after a period of abstinence. Severe epigastric pain, nausea and cyclic vomiting followed this. She had previously experienced similar gastrointestinal symptoms, relieved by compulsive hot water bathing, and resolving after marijuana cessation. Recent resumption of marijuana use was followed by a recurrence of these symptoms, a pattern characteristic of CHS. The association of cardiomyopathy with CHS has been described only once in the literature, and if this is a true relationship, its mechanism is not clearly defined. Animal models have suggested that endocannabinoid receptors are expressed in the myocardium, which could be a pathway for developing cardiac manifestations with cannabinoid use.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug Toxicity: Risk factors
Cardiomyopathy II: Dilated Cardiomyopathy

